Disopyramide phosphate and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is found among people who take Disopyramide phosphate, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Disopyramide phosphate and have Stroke. It is created by eHealthMe based on reports of 441 people who have side effects when taking Disopyramide phosphate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

441 people reported to have side effects when taking Disopyramide phosphate.
Among them, 6 people (1.36%) have Stroke.

What is Disopyramide phosphate?

Disopyramide phosphate has active ingredients of disopyramide phosphate. It is often used in heart palpitations. eHealthMe is studying from 455 Disopyramide phosphate users for its effectiveness, alternative drugs and more.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 3,580 drugs and 2,963 conditions by eHealthMe.

Number of Disopyramide phosphate and Stroke reports submitted per year:

Could Disopyramide phosphate cause Stroke?

Gender of people who have Stroke when taking Disopyramide phosphate *:

female: 0.0 %
male: 100 %

Age of people who have Stroke when taking Disopyramide phosphate *:

Common drugs people take besides Disopyramide phosphate *:

Common side effects people have besides Stroke *:

Unresponsive To Stimuli: 3 people, 50.00%
Hypotension (abnormally low blood pressure): 3 people, 50.00%
Carotid Artery Stenosis (narrowing of carotid artery): 3 people, 50.00%
Confusional State: 3 people, 50.00%
General Physical Health Deterioration (weak health status): 3 people, 50.00%
Anaemia (lack of blood): 3 people, 50.00%
Hypovolaemia (a decreased volume of circulating blood in the body): 2 people, 33.33%
Muscle Haemorrhage (bleeding in muscle): 2 people, 33.33%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 33.33%
Fatigue (feeling of tiredness): 2 people, 33.33%

Common conditions people have *:

Pain: 5 people, 83.33%
Sleep Disorder: 2 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 2 people, 33.33%
Laxative Supportive Care: 2 people, 33.33%
Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 2 people, 33.33%
Heart Attack: 2 people, 33.33%
Essential Hypertension (primary hypertension): 2 people, 33.33%
Cardiomyopathy (weakening of the heart muscle): 2 people, 33.33%
Cardiac Disorder: 2 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Disopyramide phosphate and have Stroke?

Check whether Stroke is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Stroke treatments and more:

Stroke (311,149 reports)

COVID vaccines that are related to Stroke:

Common drugs associated with Stroke:

All the drugs that are associated with Stroke:

Stroke (3,580 drugs)

Common conditions associated with Stroke:

Diabetes: 23,370 reports
High blood pressure: 8,572 reports
Rheumatoid arthritis: 7,082 reports
Multiple sclerosis: 6,381 reports
Atrial fibrillation/flutter: 5,921 reports
Arthritis: 5,814 reports

All the conditions that are associated with Stroke:

Stroke (2,963 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on disopyramide phosphate (the active ingredients of Disopyramide phosphate) and Disopyramide phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.